Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000041755 | SCV000065451 | benign | not specified | 2013-02-06 | criteria provided, single submitter | clinical testing | Thr4742Thr in exon 65 of USH2A: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue and has been identifi ed in 1.8% (80/4406) of African American chromosomes by the NHLBI Exome Sequenci ng Project (http://evs.gs.washington.edu/EVS/). |
Athena Diagnostics | RCV000714159 | SCV000844842 | benign | not provided | 2018-05-24 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000714159 | SCV001038581 | benign | not provided | 2025-02-03 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000041755 | SCV001157349 | benign | not specified | 2018-09-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000714159 | SCV001905413 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003450787 | SCV004183089 | benign | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003450786 | SCV004183090 | benign | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000714159 | SCV005287598 | benign | not provided | criteria provided, single submitter | not provided | ||
Clinical Genetics, |
RCV000041755 | SCV001921841 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000041755 | SCV001953009 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000041755 | SCV001971805 | benign | not specified | no assertion criteria provided | clinical testing |